BioMed Valley Discoveries, Inc., is a for-profit, disease-related research and development organization, whose mission is to address unmet medical needs in areas that are considered too early, too unconventional or too unprofitable for traditional biotech and pharmaceutical companies. Operating since 2007, BVD advances its mission with commercial capabilities and resources typically unavailable to academic institutions. As a member of the Stowers Group of Companies, BVD receives its funding principally from an endowment supporting the Stowers Institute for Medical Research, a non-profit 550-person basic biomedical research organization. One hundred percent of the profits from BVD accrue to the benefit of the Stowers Institute.
May 29 - June 2, 2015: Members of BioMed Valley Discoveries attended the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Jeffrey Infante, MD, from Sarah Cannon Research Hospital presented recent BVD-523 clinical trial results on June 2, 2015.Dr Jeffrey Infante Explains Phase 1 Study for Patients with Advanced Solid Tumors